Last reviewed · How we verify

NCT03952689

Automatic Urine Output Measuring Device Performance Validation and Efficacy.

Status unknown NA Last updated 22 October 2020
What this trial tests

NA trial testing Serenno Medical Automatic Urine Output measuring device in Urine Output Decreased in 60 participants. Status unknown.

Timeline
14 May 2019
Primary endpoint
14 October 2021
14 October 2021

Quick facts

Lead sponsorSheba Medical Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment60
Start date14 May 2019
Primary completion14 October 2021
Estimated completion14 October 2021
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Sheba Medical Center

Who can join

18 and older, any sex, with Urine Output Decreased. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy of Serenno Medical Automatic Urine Output measuring device in patients with indwelling urinary catheter hospitalized in the cardiac surgery intensive care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Urine Output Decreased

Currently open trials in the same condition.

Other Sheba Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03952689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing